Clinical experience with bacteraemia in patients with leukaemia and allied neoplastic diseases.
134 bacteraemic episodes in 112 patients with leukaemia and allied disorders over a 5-year period were reviewed. The patients were divided, with respect to neoplastic disease, into 3 prognostic groups according to estimated periods of survival of years (group 1), months (group II) or weeks (group III). High mortality was correlated to group III, gram-negative rod bacteraemia and septic shock. Low leucocyte levels and intensive antineoplastic treatment did not adversely influence the prognosis of the bacteraemic patients. Appropriate antibiotic therapy was correlated with a significantly lower mortality, and it is concluded that aggressive antibiotic therapy is indicated when bacteraemia is suspected from clinical judgement.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy; D007958:Leukocyte Count; D008223:Lymphoma / Q000150:complications* / Q000188:drug therapy; D055728:Primary Myelofibrosis / Q000150:complications* / Q000188:drug therapy; D011379:Prognosis; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology*
D000900:Anti-Bacterial Agents